We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.

Biosimilars Updates

Regularly updated material to support the introduction of adalimumab, eculizumab, natalizumab, ranibizumab and tocilizumab biosimilars.